Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2430473135;73136;73137 chr2:178573222;178573221;178573220chr2:179437949;179437948;179437947
N2AB2266368212;68213;68214 chr2:178573222;178573221;178573220chr2:179437949;179437948;179437947
N2A2173665431;65432;65433 chr2:178573222;178573221;178573220chr2:179437949;179437948;179437947
N2B1523945940;45941;45942 chr2:178573222;178573221;178573220chr2:179437949;179437948;179437947
Novex-11536446315;46316;46317 chr2:178573222;178573221;178573220chr2:179437949;179437948;179437947
Novex-21543146516;46517;46518 chr2:178573222;178573221;178573220chr2:179437949;179437948;179437947
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Fn3-64
  • Domain position: 83
  • Structural Position: 115
  • Q(SASA): 0.1978
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/E rs375958762 -1.182 1.0 D 0.913 0.642 None gnomAD-4.0.0 6.87582E-07 None None None None I None 0 0 None 0 0 None 0 0 9.03058E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.8272 likely_pathogenic 0.7859 pathogenic -0.622 Destabilizing 1.0 D 0.763 deleterious D 0.568962811 None None I
G/C 0.9293 likely_pathogenic 0.9127 pathogenic -0.888 Destabilizing 1.0 D 0.879 deleterious None None None None I
G/D 0.9483 likely_pathogenic 0.9351 pathogenic -1.066 Destabilizing 1.0 D 0.921 deleterious None None None None I
G/E 0.9651 likely_pathogenic 0.9559 pathogenic -1.212 Destabilizing 1.0 D 0.913 deleterious D 0.580319116 None None I
G/F 0.9905 likely_pathogenic 0.988 pathogenic -1.217 Destabilizing 1.0 D 0.899 deleterious None None None None I
G/H 0.9824 likely_pathogenic 0.9772 pathogenic -0.971 Destabilizing 1.0 D 0.878 deleterious None None None None I
G/I 0.9877 likely_pathogenic 0.985 pathogenic -0.596 Destabilizing 1.0 D 0.903 deleterious None None None None I
G/K 0.9801 likely_pathogenic 0.9749 pathogenic -1.189 Destabilizing 1.0 D 0.912 deleterious None None None None I
G/L 0.9829 likely_pathogenic 0.9781 pathogenic -0.596 Destabilizing 1.0 D 0.886 deleterious None None None None I
G/M 0.988 likely_pathogenic 0.985 pathogenic -0.443 Destabilizing 1.0 D 0.877 deleterious None None None None I
G/N 0.9557 likely_pathogenic 0.9438 pathogenic -0.764 Destabilizing 1.0 D 0.86 deleterious None None None None I
G/P 0.9984 likely_pathogenic 0.998 pathogenic -0.569 Destabilizing 1.0 D 0.911 deleterious None None None None I
G/Q 0.9669 likely_pathogenic 0.9585 pathogenic -1.085 Destabilizing 1.0 D 0.92 deleterious None None None None I
G/R 0.9501 likely_pathogenic 0.9377 pathogenic -0.677 Destabilizing 1.0 D 0.921 deleterious D 0.5692163 None None I
G/S 0.6911 likely_pathogenic 0.6474 pathogenic -0.913 Destabilizing 1.0 D 0.859 deleterious None None None None I
G/T 0.9341 likely_pathogenic 0.9227 pathogenic -1.0 Destabilizing 1.0 D 0.912 deleterious None None None None I
G/V 0.9711 likely_pathogenic 0.965 pathogenic -0.569 Destabilizing 1.0 D 0.897 deleterious D 0.580826095 None None I
G/W 0.9831 likely_pathogenic 0.9785 pathogenic -1.4 Destabilizing 1.0 D 0.885 deleterious None None None None I
G/Y 0.9826 likely_pathogenic 0.9787 pathogenic -1.067 Destabilizing 1.0 D 0.899 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.